Karuna Therapeutics Inc. (KRTX)

14.82
NASDAQ : Health Technology
Prev Close 15.58
Day Low/High 14.19 / 17.05
52 Wk Low/High 11.24 / 29.00
Avg Volume 91.80K
Exchange NASDAQ
Shares Outstanding 23.41M
Market Cap 364.77M
EPS -0.80
Div & Yield N.A. (N.A)

Latest News

Karuna Therapeutics To Present At The 2019 Wedbush PacGrow Healthcare Conference

Karuna Therapeutics To Present At The 2019 Wedbush PacGrow Healthcare Conference

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced that Andrew Miller, Ph.

Karuna Therapeutics Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares

Karuna Therapeutics Announces Closing Of Initial Public Offering And Full Exercise Of The Underwriters' Option To Purchase Additional Shares

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the closing of its initial public offering of 6,414,842...

Karuna Therapeutics Announces Pricing Of Upsized Initial Public Offering

Karuna Therapeutics Announces Pricing Of Upsized Initial Public Offering

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the pricing of its upsized initial public offering of...